Expert Oversight - Expert Witness - Litigation Support - Personal Pharmacy Consulting


The speed of change in new drug development, evidence-based medicine, and best practice requires a strong base of understanding and an ongoing study of new medication innovations and utilization. Whether you are an attorney seeking out a better experience of a complex pharmacy-related case or an individual seeking clarity for a parent with multiple medications, you will find help here.

The time will arise when a detailed explanation of drug-related topics is needed, which will be the time for a targeted discussion. As an expert in the pharmacy field, I have aided many professionals with evaluating documents with or without a written opinion. Microconsulting allows attorneys and individuals to consult without a signed contract. This conversation will establish the need for an expert, support of your case, or general knowledge of pharmacy practice.

You have located the needed resources when searching for services such as; expert witness, expert witness, expert pharmacist, specialist pharmacist, pharmacist expert witness, or consulting pharmacist. With the experience of working on various pharmacy-legal cases, you will be assured that years of clinical and practical experience will aid your understanding of complex drug-related topics.

Follow the links to the pages above, as they will lead you to the services provided and the expertise available. Instead, you choose to call or send a note, and you will be pleased with the responsiveness and level of service offered. Attorneys, pharmaceutical companies, insurance companies, and individuals will find the legal consulting services necessary to achieve their goals and outcomes with Grant Clinical Consulting working with them.

Thank you for visiting,

Dr. Wayne Grant

Dr. Wayne H


Dr. Wayne H. Grant has been a registered pharmacist, in good standing, in the State of Ohio, since 1990. He received his Bachelor of Pharmacy degree from Ohio Northern University, Ada, Ohio, in 1990, a Doctor of Pharmacy degree from the University of Florida, Gainesville, Florida, in 2007, and an MBA from Kent State University in 2016. Employed by a hospice in Cleveland, Ohio, current clinical practice is in hospice and palliative care, targeting disease state management in multiple areas including but not limited to; cardiology, gastrointestinal, geriatrics, nephrology, oncology, psychiatry, and pulmonology.

Dr. Grant has prepared and delivered educational classes to nursing professionals on pain management, heart failure, chronic obstructive pulmonary disease, chronic kidney disease, dementia, and cancer-related problems. Sitting on multiple committees, including the pharmacy and therapeutics, renal, and quality, He can promote the importance and appropriateness of pharmacy intervention.

Paramount to his current practice is a detailed understanding of pain management. Dosage routes from oral, intravenous, intrathecal, and others, in conjunction with strong opioids and adjuvants, garner much of Dr. Grant’s attention.

Expertise in long-term, institutional, infusion, and retail practice compose of an extensive understanding of the various pharmacy sectors. ADr. Grant utilizes current evidence-based medicine to foster best practices as an adjunct clinical assistant professor at the University of Florida, College of Pharmacy, Department of Pharmacotherapy and Translational Research, Dr. Grant utilizes current evidence-based medicine to foster best practices. Additionally, he teaches pharmacy students from Ohio Northern University and The Ohio State Universitcompleteleting clinical rotations in their final year before graduation.

Dr. Grant has delivered local, state, national, and international speaking programs reflective of the fundamental practice of pharmacy. As a peer reviewer for the American Journal of Health-System Pharmacy, he has provided feedback on articles that will determine future drug therapies. A history of clinical practice, management, and education culminates present-day understanding of the pharmacy profession.


Provide a service based on the fundamental practice of pharmacy. Clients will become knowledgeable of specific medication choices through review, interpretation, and application of evidence-based medicine. Integrating the latest research and practice standards will aid in achieving this objective. The cornerstone of this mission is providing a transparent, open, and honest discussion of the individual circumstance while maintaining respect for the client’s privacy and choice regardless of the opinions and recommendations offered.


The mechanism of delay-nausea (>24hours) involves stimulation of neuroreceptors other than serotonin. Dopamine mediations dominate this type of nausea. This leads to the benefit seen with phenothiazines (chlorpromazine, promethazine) and butyrophenone (haloperidol). The use of 5HT-3 antagonists, such as ondansetron, is not beneficial in this phase of emesis control as it lacks dopaminergic activity. The use of other drugs, such as dexamethasone, metoclopramide, droperidol, and olanzapine, may provide relief.


Methadone, an agonist of mu and delta and an antagonist at the NMDA (N-methyl-D-aspartate) receptor, offers a unique treatment option. Pain negatively affects the NMDA receptor through what is postulated as an interaction on the excitatory transmitters (glutamate and aspartate), resulting in central sensitization. Using an NMDA blocking agent is thought to reduce or interfere with the discharge threshold, making it less sensitive and able to restrain the transmittal of pain signals.